☰

Olivia K. Giddings, MD PhD

Affiliations: 
2006 Saint Louis University, St. Louis, MO, United States 
 2018- Rainbow Babies and Children's Hospital 
Area:
Microbiology Biology, Immunology
Google:
"Olivia Giddings"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Daniel F. Hoft grad student 2006 Saint Louis University
 (Conjunctival infection with Trypanosoma cruzi: A model for the study of mucosal immune responses and vaccine development.)
Charles R. Esther Jr X 2013-2017 UNC Chapel Hill (Bronchopulmonary Tree)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sullivan NL, Eickhoff CS, Zhang X, et al. (2011) Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation. Journal of Immunology (Baltimore, Md. : 1950). 187: 1358-68
Eickhoff CS, Giddings OK, Yoshida N, et al. (2010) Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection. MemóRias Do Instituto Oswaldo Cruz. 105: 687-91
Giddings OK, Eickhoff CS, Sullivan NL, et al. (2010) Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. Infection and Immunity. 78: 1333-8
Hoft DF, Eickhoff CS, Giddings OK, et al. (2007) Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. Journal of Immunology (Baltimore, Md. : 1950). 179: 6889-900
Giddings OK, Eickhoff CS, Smith TJ, et al. (2006) Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infection and Immunity. 74: 5549-60
Carruthers VB, Håkansson S, Giddings OK, et al. (2000) Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infection and Immunity. 68: 4005-11
See more...